ATHENS, Greece, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE: ECO, OSE: OET) is pleased to announce that it has successfully priced an offering of 3,611,111 new shares of the Company’s common stock, par value USD 0.001 per share (the “Offer Shares”), at a price of USD 36.00 per Offer Share, raising gross proceeds of approximately USD 130 million (the “Offering”). The net proceeds from the Offering are expected to be used as partial consideration for the acquisit ...

Core Viewpoint - Ondas Holdings Inc. has announced a $1 billion registered direct offering of common stock and pre-funded warrants, aimed at institutional investors, to support corporate development and strategic growth initiatives [1][3]. Offering Details - The offering consists of 19,000,000 shares of common stock and pre-funded warrants to purchase up to 41,790,274 shares, totaling 60,790,274 Common Stock Equivalents [1][2]. - Each share of common stock is priced at $16.45, while each pre-funded warrant is priced at $16.4499, representing a premium of approximately 17.5% over the closing stock price on January 8, 2026 [2]. - The offering is expected to close on or about January 12, 2026, pending customary closing conditions [2]. Financial Projections - Ondas anticipates gross proceeds of approximately $1 billion from the offering, with potential additional proceeds of about $3.4 billion if all common stock warrants are exercised [3]. - The net proceeds will be utilized for corporate development, including acquisitions, joint ventures, and investments [3]. Placement Agents - Oppenheimer & Co. Inc. is the lead placement agent for the offering, with several other firms acting as co-placement agents [4].

Group 1 - Denali Therapeutics Inc. plans to offer and sell $200 million of its common stock and pre-funded warrants to certain investors in an underwritten public offering, with an additional $30 million option for underwriters [1] - The offering is subject to market conditions, and there is no assurance regarding its completion or the final terms [1] - Goldman Sachs, J.P. Morgan, Morgan Stanley, and Jefferies are acting as joint book-running managers for the offering, with H.C. Wainwright as co-manager [2] Group 2 - The shares will be offered under a Registration Statement on Form S-3, which became effective upon filing with the SEC on February 27, 2025, and a preliminary prospectus supplement will be filed [3] - Copies of the preliminary and final prospectus supplements can be obtained from the respective underwriters [4] Group 3 - Denali Therapeutics is a biotechnology company focused on developing biotherapeutics that can cross the blood-brain barrier using its proprietary TransportVehicle™ platform, aiming to deliver effective medicines for neurodegenerative and other serious diseases [6]

Core Insights - SoFi is conducting a stock offering valued at approximately $1.5 billion, which has contributed to recent stock weakness [1][5] - Despite recent declines, SoFi's stock has increased by about 68% year-over-year, indicating strong performance over the past 52 weeks [2] - The company has turned profitable, achieving a profit margin of around 19% based on the trailing four quarters [3] Financial Performance - SoFi generated approximately $640 million in profit from $3.3 billion in sales, marking a significant turnaround from a loss of $340 million on $2 billion in revenue two years ago [4] - The stock offering involves the issuance of an additional 54.5 million shares, representing about 5% of the total common equity in free float [5][7] Market Context - The stock offering is seen as a healthy move for the company, aimed at financing operational expenses and expansion efforts [6] - The overall market conditions may also be influencing SoFi's stock performance, with potential capital rotation contributing to price movements [8][12] - The recent downturn in SoFi's stock may be partially attributed to broader trends in the crypto market, as the company operates in high-growth areas of finance [11]

Group 1 - Warner Bros. Discovery shares fell after being downgraded by TD Cowan due to concerns that potential gains from a sale to Paramount Skydance could be lost if the deal does not materialize [1][2][5] - The S&P 500 and Nasdaq experienced declines from record highs as the Federal Reserve's two-day meeting commenced, with Warner Bros. Discovery being the worst-performing stock in the S&P 500 [2][5] - Dave & Buster's Entertainment shares plunged after missing profit and sales estimates, with comparable store sales declining and warnings about inflation and tariffs affecting business [3][5] Group 2 - Novo Nordisk shares rose following positive results from a Phase 3 trial of a new weight-loss drug that operates differently from traditional GLP-1 inhibitors [4] - Steel Dynamics shares advanced after providing a better-than-expected outlook on performance across its units [5] - Rocket Lab shares declined as the company announced agreements to sell $750 million in stock to raise cash [3]

Core Viewpoint - Lake Shore Bancorp, Inc. has received approval from stockholders and members for its conversion plan from a mutual holding company to a fully public stock holding company, along with the Bank's transition to a New York chartered commercial bank [1] Group 1: Company Overview - Lake Shore Federal Bancorp is the mid-tier holding company for Lake Shore Savings Bank, which is a federally chartered, community-oriented financial institution based in Dunkirk, New York [4] - The Bank operates ten full-service branch locations in Western New York, providing a wide range of retail and commercial lending and deposit services [4] - Lake Shore Federal Bancorp's common stock is traded on the NASDAQ Global Market under the ticker symbol "LSBK" [4] Group 2: Conversion and Reorganization - The special meetings held on July 1, 2025, resulted in the approval of the Amended and Restated Plan of Conversion and Reorganization [1] - The completion of the conversion and stock offering is contingent upon receiving final regulatory approvals and meeting customary closing conditions [2]

Core Viewpoint - Lake Shore Bancorp, Inc. is initiating a common stock offering as part of its conversion from a mutual holding company to a stock holding company, which includes renaming the Bank to Lake Shore Bank and converting its charter to a New York commercial bank [1][4]. Group 1: Stock Offering Details - Lake Shore Bancorp is offering up to 5,750,000 shares of common stock at a price of $10.00 per share, with the possibility of increasing to 6,612,500 shares [2]. - The stock will be available to eligible depositors and the employee stock ownership plan, with a community offering for unsubscribed shares, prioritizing residents of Chautauqua, Erie, and Cattaraugus counties [2]. - A minimum of 4,250,000 shares must be sold to complete the conversion and stock offering, subject to regulatory approvals and customary closing conditions [4]. Group 2: Company Background - Lake Shore Federal Bancorp is the mid-tier holding company for Lake Shore Savings Bank, a community-oriented financial institution based in Dunkirk, New York, with ten full-service branches in Western New York [6]. - The Bank provides a range of retail and commercial lending and deposit services, and its common stock is traded on NASDAQ under the symbol "LSBK" [6]. Group 3: Contact and Information - For inquiries regarding the conversion and stock offering, interested parties can contact the Stock Information Center, which will operate from May 27, 2025, to June 24, 2025 [3]. - Additional information about the company and the stock offering can be accessed through the SEC's website or by contacting Lake Shore Bancorp directly [9].

Registration Number 333-279092 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) As filed with the Securities and Exchange Commission on May 13, 2024. Delaware 2834 26-2844103 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification ...

As filed with the Securities and Exchange Commission on May 13, 2024. Registration Number 333-279092 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 26-2844103 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification ...

As filed with the Securities and Exchange Commission on May 3, 2024. Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 26-2844103 (I.R.S. Employer Identification No.) 627 Davis Drive, Sui ...